---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-24-000681"
form_type: "8-K/A"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2024-04-24T23:59:59+00:00"
generated_at: "2026-06-03T09:37:26.207046+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Renovaro Cube audited: €2.1M net loss post-acquisition, going concern noted

## Summary
- Successor period (Aug 24–Dec 31, 2023) net loss of €2,100,579, no revenue generated.
- Accumulated deficit of €2,100,579; cash only €114,520 at Dec 31, 2023.
- Auditor includes going-concern explanatory paragraph citing negative operating cash flows and deficit.
- Predecessor (Grace Systems) net loss €129,572 for Jan 1–Aug 23, 2023 and €623,982 for FY 2022.
- Acquisition of Grace Systems by Renovaro Cube treated as asset acquisition; company in development stage.

## SEC filing metadata
- accession: 0001731122-24-000681
- form_type: 8-K/A
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2024-04-24T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000681/0001731122-24-000681-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000681/e5613_8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-24-000681
- JSON: https://secwatch.observer/filing/0001731122-24-000681.json
- Plain text: https://secwatch.observer/filing/0001731122-24-000681.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.